Justice Samuel A. Alito Jr. has paused until at least Thursday a federal appeals court ruling against the Food and Drug Administration that would restrict access by mail to mifepristone.
Previous Story
Lawmakers Urge Trump to Move Ahead on Delayed Arms Sale to Taiwan
Next Story
Why Republicans Are Still Drawing House Maps, While Democrats Are Stuck